Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Baltimore, Maryland 21205


Purpose:

The primary aims are to test the effectiveness of the self-help DM intervention (SHIP-DM), a comprehensive, culturally tailored DM management intervention, in improving glucose outcomes; To determine the effectiveness of the SHIP-DM in KAI with type 2 DM in improving self-care skills and psycho-behavioral outcomes related to DM control, to develop tangible infrastructures for the dissemination of valid and effective education materials to a wider population of KAI with type 2 DM in the US (e.g., audio-visual education materials, web-based intervention materials, mobile telephone-based intervention materials) and to explore the feasibility and acceptability of each dissemination module, utilizing the delayed intervention group participants. The secondary aims are to obtain preliminary cost-effectiveness data related to the proposed intervention, including cost estimates for this type of DM intervention, and to establish a systematic, long-term dissemination plan, including documenting effective methodologies, to facilitate faster translation of research findings and products to direct consumers in non-research settings.


Study summary:

Inclusion Criteria 1. Self-identified as a first generation Korean American 2. Type 2 diabetes 3. Age 30-75 years 4. Resides in Washington-Baltimore area 5. Self-identified with DM and HbA1c >= 7.0 % within 6 months of screening 6. Expresses willingness to participate in all aspects of the study over its full course Exclusion criteria 1. Unable to give informed consent 2. Physical or mental health conditions that could limit active participation in the study (e.g., blindness in both eyes, severe immobility, psychiatric diseases) 3. Hematological condition that would affect A1C assay, e.g., hemolytic anemia, sickle cell anemia 4. Past experience in diabetes group education


Criteria:

Inclusion Criteria: 1. Self-identified as a first generation Korean American 2. Type 2 diabetes 3. Age 30-75 years 4. Resides in Washington-Baltimore area 5. Self-identified with DM and HbA1c >= 7.0 % within 6 months of screening 6. Expresses willingness to participate in all aspects of the study over its full course Exclusion Criteria: 1. Unable to give informed consent 2. Physical or mental health conditions that could limit active participation in the study (e.g., blindness in both eyes, severe immobility, psychiatric diseases) 3. Hematological condition that would affect A1C assay, e.g., hemolytic anemia, sickle cell anemia 4. Past experience in diabetes group education


NCT ID:

NCT01264796


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Baltimore, Maryland 21205
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.